The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders

QR Code

The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders

One of the trends in modern cardiology is the use of omega-3 polyunsaturated fatty acids (ω-3 PUFA) in the prevention of heart rhythm disorders and the prevention of sudden cardiac death. In experimental studies, it was found that ω-3 PUFAs have a variety of pleiotropic effects: they reduce the form...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. I. Podzolkov, A. I. Tarzimanova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2020-07-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	omega-3 fatty acids atrial fibrillation arrhythmias sudden cardiac death prevention
Online Access:	https://www.rpcardio.online/jour/article/view/2231
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
by: A. O. Malygin, et al.
Published: (2015-09-01)

Omega-3 polyunsaturated fatty acids in the prevention of postoperative atrial fibrillation in open heart surgery: a systematic review and meta-analysis
by: O. A. Rubanenko, et al.
Published: (2023-03-01)

Role of genetic research in the prevention of life-threatening rhythm and cardiac conduction disorders in young people
by: E. N Loginova, et al.
Published: (2022-11-01)

Are There the Antiarrhythmic Effects of Omega3 Polyunsaturated Fatty Acids in Cardiosurgical Patients?
by: V. V. Lomivorotov, et al.
Published: (2014-10-01)

NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION
by: A. I. Martinov, et al.
Published: (2016-01-01)

Role of omega-3 polyunsaturated fatty acids in cardiovascular risk management
by: V. I. Podzolkov, et al.
Published: (2020-07-01)

Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment
by: Königs A, et al.
Published: (2016-07-01)

Eurasian association of cardiology (EAC) guidelines for the prevention and treatment of ventricular heart rhythm disorders and prevention of sudden cardiac death (2022)
by: S. P. Golitsyn, et al.
Published: (2022-12-01)

THE IMPACT OF EPILEPTIC SEIZURES ON THE HEART RHYTHM AND CONDUCTION: A REVIEW ARTICLE
by: Yu. V. Rubleva, et al.
Published: (2018-02-01)

Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year
by: N. G. Gogolashvili, et al.
Published: (2011-10-01)

DX single-lead implantable cardioverter-defibrillator system with a floating atrial dipole: when, to whom, and why?
by: A. V. Prokopenko, et al.
Published: (2023-06-01)

Omega-3 polyunsaturated fatty acids in cardiology
by: N. V. Perova
Published: (2005-08-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS AND COGNITIVE DEVELOPMENT OF CHILDREN
by: O. A. Gromova, et al.
Published: (2011-01-01)

Decades of Shifting Trends: Arrhythmia‐Related Mortalities in the United States (1968–2021) With 2040 Projections
by: Mohammed Mhanna, et al.
Published: (2025-06-01)

Omega-3 index of erythrocytes and predictors of sudden cardiac death in patients with coronary heart disease and ventricular arrhythmias
by: E. M. Gavva, et al.
Published: (2012-08-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
by: A. G. Pronin, et al.
Published: (2020-12-01)

Role of omega-3 unsaturated acids in prevention and treatment of different diseases (part 2)
by: M. N. Sinkova, et al.
Published: (2021-06-01)

Role of omega-3 unsaturated acids in prevention and treatment of different diseases (part 1)
by: E. Yu. Plotnikova, et al.
Published: (2021-06-01)

A POSSIBILITY TO USE ANTIARRHYTHMIC MEDICATIONS FROM II CLASS AND MODULATED KINESITHERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN METABOLIC SYNDROME PATIENTS
by: A. I. Olesin, et al.
Published: (2015-11-01)

CLINICAL AND STATISTICAL EVALUATION OF THE CALLS OF PATIENTS WITH ATRIAL FIBRILLATION
by: N. F. Plavunov, et al.
Published: (2018-10-01)

Statins and their antiarrhythmic activity
by: N. Sh. Zagidullin, et al.
Published: (1970-01-01)

Electrocardiographic parameters and features of ventricular arrhythmias in various arrhythmogenic cardiomyopathy forms in the pediatric population: a systematic review and meta-analysis
by: D. Yu. Alekseeva, et al.
Published: (2022-09-01)

Abnormal Pre-Participation Cardiac Screening in Athletes
by: Raghav T. Bhatia, MBBS, PhD, et al.
Published: (2025-08-01)

The morphological characteristic of regenerative neuroma of peripheral nerve in conditions of its injury and application of omega-3-polyunsaturated fatty acids.
by: Korsak A.V., et al.
Published: (2007-01-01)

Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases
by: A. N. Zakirova, et al.
Published: (2022-05-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women
by: D. A. Napalkov, et al.
Published: (2024-06-01)

CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
by: E. V. Privalova, et al.
Published: (2013-02-01)

CLINICAL AND ELECTROCARDIOGRAPHIC SYNDROMES ASSOCIATED WITH THE RISKOF SUDDENCARDIAC DEATH: PATHOGENESIS, CLINICAL MANIFESTATIONS, DIAGNOSTIC CRITERIA, INDICATIONS FORGENETIC RESEARCHAND TREATMENT
by: V. V. Rezvan, et al.
Published: (2016-03-01)

Evaluation of the role of omega-3 fatty acids in nicotine-induced neurotoxicity in pregnant Wistar rats and their pups
by: Joseph Gbenga Omole, et al.
Published: (2025-12-01)

Effects of omega-3 fatty acids supplementation on lipids and pregnancy outcomes in pregnant women
by: Weijing Wang, et al.
Published: (2025-12-01)

Danon disease in women: a modern view of the problem: a case series
by: R. P. Myasnikov, et al.
Published: (2024-12-01)

IS THERE ANY PLACE LEFT FOR OMEGA-3 FATTY ACIDS IN CARDIAC SURGERY?
by: V. V. Lomivorotov, et al.
Published: (2018-01-01)

Complex approach to myocardial electric instability in coronary heart disease patients
by: V. V. Popov
Published: (2006-08-01)

Experimental modeling of sudden death pathological mechanisms in Na+ channel blocker treatment
by: V. M. Moroz, et al.
Published: (2006-06-01)

Potassium Profiling in Hemodialysis
by: Nikhil Agrawal, et al.
Published: (2018-08-01)

Electrical alternans of the Q-T interval and fatal arrhythmias caused by neonatal cardiac tumor: a case report
by: Ge Wang, et al.
Published: (2025-07-01)

CARDIOSTIMULATION AND RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE
by: S. I. Stupakov
Published: (2015-06-01)

ω3-polyunsarturated fatty acid medications in cardiovascular event prevention
by: K. A. Talitsky, et al.
Published: (2006-12-01)

Biophysical modeling indicates a high affinity of ethyl esters of omega-3 polyunsaturated fatty acids to the enzymes of the pro-inflammatory arachidonic acid cascade
by: I. Yu. Torshin, et al.
Published: (2022-07-01)